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Proteinuria 
Goni Katz-Greenberg, MD
Transplant Nephrology Fellow
Outline and objectives
DEFINITION SCREENING/ 
MEASUREMENT  
ETIOLOGY TREATMENT
• Normal protein excretion < 150mg daily
• Normal albumin excretion < 30mg daily
• Moderately increased albuminuria 30-299mg daily (formerly 
microalbuminuria) over 3-6 months*
• Severely increased albuminuria > 300mg daily (formerly 
macroalbuminuria)
• Nephrotic range proteinuria > 3.5 grams daily
Definition of Proteinuria
Measurement of Proteinuria
• Albumin excretion above 300 
mg/day is considered overt 
albuminuria à the level at 
which the standard dipstick 
becomes positive
• Dipstick – ALBUMIN
• 24-hour urine test - gold 
standard, but cumbersome
• Urine protein:creatinine
ratio/ spot ratio
• The gold standard for measurement of protein excretion is 
a 24-hour urine collection (normal value <150 mg/day).
• Adults under the age of 50 years, daily creatinine excretion 
should be 
• 20 to 25 mg/kg of lean body weight in men 
• 15 to 20 mg/kg of lean body weight in women
• From the ages of 50 to 90 years, there is a progressive 50% 
decline in creatinine excretion due primarily to a fall in 
muscle mass
24-hour urine collection
• UPCR best done as spot first- or second-morning urine 
sample after avoiding exercise
• It is a RATIO, and is best when done in a steady state
• Individuals with large muscle mass, the UPCR (or UACR) 
will underestimate proteinuria
• In cachectic/small muscle mass patients, the UPCR (or 
UACR) will overestimate proteinuria
UPCR
Mr. Jones is a 69 years old male who comes to clinic 
complaining of increased abdominal girth and leg swelling for 
the past 4 weeks. His other PMHx is significant for HTN and 
hyperlipidemia.
Physical exam -
• Temperature 37.2C (98.9)
• BP 135/68, HR 85
• HEENT – WNL
• Chest – clear to auscultation
• Heart – S1S2, no murmurs or gallops
• Abdomen – distended, non tender 
• LEs – Edema +3 bilaterally, to hip level
Case 1
• Nephrotic Syndrome
• Cirrhosis 
• Heart failure 
• Myxedema 
Case 1 – Cont’d – Differential Diagnosis 
• Albumin 
• BUN, creatinine
• Urinalysis 
• 24-hour urine protein/ UPCR in random sample
• Serum LDL and cholesterol 
• LFTs ? 
Case 1 – Cont’d – Work up 
Albumin 2.8g/dL
Creatinine 1.1mg/dL
BUN 25
Urinalysis + 4 protein, with oval fat bodies seen. 
Few RBC, no casts.
UPCR 8.5g/g
T. chol 310 mg/dL
Nephrotic Syndrome 
• Urine protein exertion of > 
3.5 gram/ 24 hours (or UPCR 
of > 3000mg/g)
• Hypoalbuminemia < 3.0 g/dL
• Edema 
• Hyperlipidemia +/- Lipidiuria
Where is the proteinuria coming from? 

Types of Proteinuria
Proteinuria
Classification
Pathogenesis Clinical Setting Level of 
proteinuria
Glomerular Increased filtration of 
macromolecules (albumin)
Primary or systemic 
diseases
Variable
Overflow Increased filtration 
(causing decreased 
reabsorptive capacity) or 
marked overproduction
Myeloma, hemolysis, 
rhabdomyolysis
Variable
Tubulointerstitial Increased excretion of low 
molecular weight proteins 
(B2 macroglobulin) from 
decreased proximal tubule 
absorption
Interstitial 
inflammation/injury, 
heavy metal 
intoxication
<3 gr/day
Post-Renal 
Proteinuria
Inflammation of urinary
tract. Non-albumin protein
UTI’s, nephrolithiasis, 
GU tumor
<1 gr/day
Back to Mr Jones…
Next steps of work up 
• HbA1C
• Anti-PLA2R autoantibody
• ANA and dsDNA antibody
• Serum C3 and C4 levels
• HBV, HCV, HIV
• In patients older than 50 
years – serum free light 
chains and serum 
protein immunofixation 
àKIDNEY BIOPSY
Nephrotic Syndrome - DD
• Diabetes Mellitus
• Lupus Nephritis
• Amyloidosis  
Systemic Diseases
• Membranous Nephropathy
• Minimal Change Disease
• Focal Segmental Glomerulosclerosis (FSGS)
Primary Diseases of the Kidney
Kidney Biopsy 
Membranous Nephropathy 
Kidney Biopsy from a different story 
An S. De Vriese.. Richard J. Glassock, and Fernando C. Fervenza Differentiating Primary, 
Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach. 
J Am Soc Nephrol 29: 759–774, 2018
Membranous Nephropathy
About 70%–80% of membranous nephropathy are classified 
as primary
The remaining 20-30% have secondary forms associated 
with autoimmune diseases, infections, drug exposure, or 
malignancy
Identification of the two target antigens PLA2R and 
THSD7A allowed the development of serologic tests for 
circulating anti-PLA2R or anti-THSD7A autoantibodies, 
and revolutionized the diagnosis and follow up

Cancer Screening
Standard cancer screening is recommended 
in all patients with glomerular lesions which 
may be associated with malignancy 
Targeted screening tests must be 
additionally performed according to each 
patient’s specific risk factors for cancer
The picture can't be displayed.
Routine and targeted cancer screening in patients with 
glomerulopathy
Thromboembolism
Patients with the nephrotic syndrome are at increased risk for 
venous thrombosis, particularly deep vein thrombosis and renal 
vein thrombosis
There is also increased risk of arterial thrombosis and pulmonary 
emboli 
The risk of thrombosis is inversely related to the serum albumin 
levels
Prophylactic anticoagulation?
When? Albumin < 2.5 g/dL
Who? 
•Membranous Nephropathy
•Pregnant patients 
• Isolated proteinuria?
• No HTN
• No hematuria
• No systemic disease
• No kidney injury/ azotemia
Proteinuria without Nephrotic Syndrome
• Common, especially in young individuals 
• Causes: fever, exercise, acute illness (eg URI), 
hyperglycemia 
• Usually < 1 gram/ day
• Test: UACR or UPCR over 1-3 months
• Avoid exercise 24-48 hours prior to test
• Diagnosis is made when repeat test is no longer positive for 
proteinuria
Transient Proteinuria 
• Increased protein excretion in the upright position but 
normal protein excretion when the patient is supine
• Relatively common in adolescents (up to 5%), but 
uncommon in adults > 30 years old
• Usually < 1 gram/ day
• Benign, but kidney function and proteinuria should be 
followed yearly
• NORMAL early morning sample (<30mg), with positive PM 
sample within 24 hours = orthostatic proteinuria
Orthostatic Proteinuria 
à Glomerular Inflammation 
• Hematuria
• Proteinuria – can be in the nephrotic range
• HTN
• Kidney injury
• Involvement of other organs
Nephritic Syndrome
Nephritic Syndrome - DD
• ANCA vasculitis (pauci-immue glomerulonephritis)
• Anti-GBM disease
• SLE
• IgA nephropathy
• TMA
Systemic
• Bacterial – Strep/ staph
• Viral – HBV, HCV, CMV
• Parasitic – Plasmodium malariae
Infections 
• The degree of proteinuria is prognostically important in 
patients with primary and secondary glomerular diseases
• Higher degrees of proteinuria are associated with a more 
rapid progression to kidney failure, even in the absence of 
nephrotic syndrome
Proteinuria - What is the big deal? 
Relative risks of Major Complications of CKD
Treatment
• Optimal HTN control: Aim BP < 130/80
• Add a diuretic for optimal HTN management
• ACEi/ARB
• Other agents that reduce proteinuria: non-dihydropyridine 
Ca Channel blockers, mineralocorticoid antagonists
• SLGT-2 inh
• Treatment for glomerular disease - IS
ACEi and ARB Therapy
• MDRD study (Annals Int Med, 
1995)
• Proteinuria is independent risk 
factor for CKD progression
• Tight BP control reduces 
proteinuria and reduces GFR 
decline
Mechanism of ACE-inhibitors
Spironolactone/Eplerenone
• Metanalysis (CJASN 2009) looked at MCA (Spironolactone 25mg 
daily) with ACEi compared to ACEi alone
• Proteinuria and HTN control improved significantly more with 
MCA + ACEi group
• No difference in GFR preservation between groups
• Higher risk Hyperkalemia with MCA+ACEi
• CREDENCE trial (NEJM 2019) double blind randomized trial, 
type II DM + albuminuria +CKD
• Canagliflozin 100mg daily or placebo
• All patients GFR 30-90, treated with RAAS blockade
• Diabetic patients with >300mg albuminuria despite 
ARB/ACEi should start a sodium-glucose co-transporter 
(SGLT-2inh)
SLGT-2 inhibitors
SLGT-2 inhibitors
• Even within the normal range, higher amounts of 
albuminuria are associated with an increased risk of 
cardiovascular disease
• For patients who are very likely to have nephrotic-range 
proteinuria due to diabetic nephropathy, biopsy can be 
deferred 
• Treat underlying cause/risk factors: 
obesity/DM/HTN/smoking/HL
Take home message 
• Start RAAS blockade: don’t wait! can start in CKDG1-
G3b safely. Expect 30% rise in creat which stabilizes
• With treatment, aim to reduce albuminuria as much as 
possible by up-titrating RAAS blockade to achieve maximum 
effect to delay CKD progression
• For type 2 DM, with eGFR > 45, and > 300mg albuminuria, 
NOT on insulin/sulfynurea, START SGLT-2 inh at lowest 
dose. Expect 30% rise in creatinine which stabilizes
Take home message - 2

• Questions? 
Thank you!

